Introduction
============

Primary rhegmatogenous retinal detachment (RD) remains an important cause of visual loss ([Figure 1](#f1-co-2-57){ref-type="fig"}). The fundamental principles of retinal attachment surgery are well defined. Specifically, all retinal breaks are identified and treated, and vitreous traction is relieved as part of the surgical strategy. The two most common re-attachment procedures performed today are scleral buckling (SB) and pars plana vitrectomy (PPV) ([@b34-co-2-57]). Pneumatic retinopexy (PR) is appropriate for selected superior detachments ([@b44-co-2-57]). Laser demarcation ([@b46-co-2-57]) and observation ([@b8-co-2-57]) may be considered in rare circumstances. PPV ([Figure 2](#f2-co-2-57){ref-type="fig"}) is growing in popularity for the treatment of primary RD ([@b40-co-2-57]). The current manuscript will review the published literature on the topic and offer guidelines based on the evidence available today.

Theoretical considerations
==========================

Successful retinal attachment surgery requires effective treatment of retinal breaks and relief of vitreoretinal traction ([@b36-co-2-57]). Traditionally, SB was considered the procedure of choice for primary RD. SB is the most well-established technique, and has the longest published follow-up data ([@b35-co-2-57]). SB has a high single-operation success rate (SOSR) and is considered for many primary retinal detachments, except cases with very posterior breaks and cases in which placing the buckling elements is too technically difficult, such as eyes with thin sclera, prior strabismus surgery, glaucoma drainage devices, etc. Additional relative contraindications to SB alone (without PPV) include giant retinal tear, proliferative vitreoretinopathy (PVR) grade C, and significant vitreous opacity or hemorrhage.

However, PPV is growing in popularity as a first-line procedure for primary RD, especially in pseudophakic patients ([@b19-co-2-57], [@b40-co-2-57]). PPV has several advantages over SB ([Table 1](#t1-co-2-57){ref-type="table"}). Perhaps the major benefit of PPV is the potential for an improved view of the retinal periphery, allowing increased identification of retinal breaks. Some authors have advocated the use of transretinal injection of trypan blue ([@b15-co-2-57]) to facilitate intraoperative localization of retinal breaks. PPV removes vitreous opacities, and allows concomitant cataract surgery or posterior capsulotomy, if necessary to further improve visualization. PPV allows for more controlled drainage of subretinal fluid, either with perfluorocarbon liquids or internal drainage techniques ([@b6-co-2-57]). This may achieve complete intraoperative retinal attachment (particularly important for giant retinal tears) without the risk of hemorrhage or retinal incarceration inherent in external drainage procedures. PPV is unlikely to cause significant motility disturbances, and is frequently less painful than SB. PPV is less likely to cause significant refractive changes than SB in pseudophakic eyes, although some phakic eyes will develop nuclear sclerosis and induced myopia following PPV.

Disadvantages and complications may also occur with PPV for primary retinal detachment ([Table 1](#t1-co-2-57){ref-type="table"}). PPV increases the risk of new retinal breaks ([@b3-co-2-57]), cataract formation ([@b17-co-2-57]), and intraocular pressure elevation ([@b18-co-2-57]). If perfluorocarbon liquids are used, they may be retained in the vitreous cavity or subretinal space ([@b30-co-2-57]). Rare complications may include retinal incarceration into a sclerotomy ([@b42-co-2-57]), displacement of a laser in situ keratomileusis (LASIK) flap ([@b45-co-2-57]), and direct retinal trauma during air-fluid exchange ([@b50-co-2-57]).

PPV is somewhat more technically difficult in phakic patients, because access to the vitreous base is impeded by the crystalline lens. Wide-angle viewing systems and external scleral indentation from a surgical assistant may be helpful ([@b47-co-2-57]). Perfluorocarbon liquids may be used to stabilize the posterior retina during these maneuvers ([@b6-co-2-57]). Removing peripheral vitreous with 25 gauge vitrectomy instrumentation can be difficult and sometimes impossible. Therefore, many surgeons prefer either 23 gauge or 20 gauge vitrectomy instrumentation for this purpose. In addition, concomitant SB or pars plana lensectomy may be considered.

Traditional teaching held that PPV for primary retinal detachment had too many disadvantages, but recent published case series have called this concept into question. These are summarized in [Table 2](#t2-co-2-57){ref-type="table"}. PPV without SB was traditionally believed to have a low SOSR in patients with inferior breaks. However, recent series have demonstrated favorable results with PPV for these patients ([@b37-co-2-57]; [@b20-co-2-57][@b21-co-2-57]). PPV was traditionally believed to require long-acting intraocular gas (or silicone oil) tamponade, especially for inferior breaks. However, recent case series have documented generally favorable results using air tamponade or even aqueous tamponade ([@b20-co-2-57]; [@b21-co-2-57]; [@b22-co-2-57]). PPV was traditionally believed to require some degree of face-down positioning for inferior breaks, but a recent case series demonstrated favorable outcomes with very limited positioning requirements ([@b22-co-2-57]).

An alternative approach to inferior, more complex RDs (large and more posterior tears, advanced proliferative vitreoretinopathy, etc.) is the use of intermediate-term, heavier-than-water tamponade agents. Some authors have advocated the use of retained intravitreal perfluorocarbon liquids, either alone or in combination with silicone oil, for post-operative internal tamponade ([@b28-co-2-57]; [@b5-co-2-57]). The combination of perflurohexyloctane (F6H8) and silicone oil has been advocated by some authors ([@b26-co-2-57]). Heavy silicone oil (Oxane HD, Bausch and Lomb, Toulouse, France) also has demonstrated some efficacy ([@b49-co-2-57]). Neither perfluorohexyloctane nor heavy silicone oil is available for routine clinical use in the United States at this time.

Clinical studies
================

The first report of PPV without concomitant SB to treat RD was published in 1985 ([@b12-co-2-57]). Since that time, numerous case series have been published ([Table 3](#t3-co-2-57){ref-type="table"}). In general, the outcomes (SOSR and visual acuity) appear comparable to those achieved with SB for a wide variety of patients. The poorest outcomes were reported in series which contained patients with chronic detachments and evidence of PVR.

Several retrospective series comparing SB, PPV, and/or combined SB/PPV have appeared in the past few years. These series describe a wide variety of clinical situations and are summarized in [Table 4](#t4-co-2-57){ref-type="table"}. The majority of these series found no statistically significant difference in SOSR among the various procedures. Similarly, visual results were generally comparable.

Similarly, an increasing number of prospective clinical trials are being reported, many of which are randomized. These are summarized in [Table 5](#t5-co-2-57){ref-type="table"}. Again, the majority of these studies found no statistically significant differences in either SOSR or visual results between the two treatment modalities.

Other literature reviews have reported conflicting results. One meta-analysis of 29 published studies of pseudophakic RD reported that both PPV and combined PPV/SB were associated with higher SOSRs and better visual acuity outcomes than was SB alone ([@b4-co-2-57]). However, another review of 9 published studies comparing PPV to SB found no statistically significant differences with respect to SOSR or visual results ([@b32-co-2-57]).

Another area of controversy regards risk of postoperative re-detachment and PVR. A recent statistical analysis reported that SB increased the risk of PVR, especially in pseudophakic cases ([@b27-co-2-57]), which contrasted an earlier report indicating the reverse ([@b11-co-2-57]).

At this time, there has been no definitive prospective, randomized, controlled clinical trial comparing SB to PPV, and this question remains unresolved ([@b23-co-2-57]). The Scleral Buckling versus Primary Vitrectomy in Rhegmatogenous Retinal Detachment (SPR) study is a European multicenter, randomized, prospective, controlled clinical trial comparing PPV to SB ([@b13-co-2-57]). The SPR study may be limited by the fact that a significant proportion of patients in the primary PPV group also received SB. As yet, no results have been published.

Conclusions
===========

Although PPV was traditionally considered a second-line procedure for rhegmatogenous RD, there is a growing body of evidence that, in certain cases, PPV represents a reasonable primary approach. However, most of the current literature comes from small case series with limited follow-up and other methodological flaws. The upcoming SPR study should provide useful guidelines.

Therefore, in the absence of convincing study data, the choice of procedure for any individual patient should be left to the surgeon's best clinical judgment, taking into account various factors such as the number, size, and position of retinal breaks; the lens status; the patient's expected ability to cooperate with postoperative positioning requirements; available operating room equipment and staff; surgeon preference; and patient preference. By avoiding a regimented approach and adopting an individualized strategy, results of RD surgery may be optimized. Although some patients will not achieve re-attachment after the initial surgery, a variety of surgical techniques are successful in the vast majority of patients.
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![Primary rhegmatogenous retinal detachment, left eye, with a flap retinal tear at 1:00.](co-2-57f1){#f1-co-2-57}

![Pars plana vitrectomy (PPV) for rhegmatogenous retinal detachment, utilizing wide-field imaging and small-gauge transconjunctival sutureless instrumentation.](co-2-57f2){#f2-co-2-57}

###### 

Pars plana vitrectomy (PPV) versus scleral buckling (SB)

                                     PPV                                             SB
  ---------------------------------- ----------------------------------------------- -----------------------------------------
  Visualization of retinal breaks    Generally better                                Generally good
  Relief of vitreoretinal traction   Direct                                          Indirect
  Location of retinal break          More effective for superior breaks              Effective regardless of break location
  Subretinal fluid drainage          Internal                                        External
  Post-operative positioning         Generally required                              Generally not required
  Post-operative pain                Generally less                                  Generally more
  Surgical costs                     Higher                                          Lower
  Advantages                         Clears vitreous opacities                       Supports "missed" breaks
                                     Giant retinal tears                             Allows early air travel
                                     Identification of "missed" breaks               
                                     Faster foveal re-attachment                     
  Potential complications            New retinal breaks                              Refractive change
                                     Elevated intraocular pressure from gas bubble   Motility disturbance
                                     Retinal or optic nerve trauma                   Retinal or vitreous incarceration
                                     Induced cataract                                Migration of buckling elements
                                     Disruption of LASIK flap                        Infection of buckling elements
                                     Moisture condensation on silicone               Suprachoroidal or subretinal hemorrhage
                                     IOL during fluid-air exchange                   
                                     Retained perfluorocarbon liquids                
                                     Retinal incarceration                           

**Abbreviations:** IOL, intraocular lens; LASIK, laser-assisted in situ keratomileusis.

Adapted from [@b34-co-2-57].

###### 

Pars plana vitrectomy: traditional teaching versus current literature

  Clinical variable   Traditional teaching                               Newer literature
  ------------------- -------------------------------------------------- -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Inferior breaks     Less effective for patients with inferior breaks   Favorable outcomes in these patients[1](#tfn3-co-2-57){ref-type="table-fn"},[2](#tfn4-co-2-57){ref-type="table-fn"},[3](#tfn5-co-2-57){ref-type="table-fn"},[4](#tfn6-co-2-57){ref-type="table-fn"}
  Gas tamponade       Importance of long-acting gas tamponade            Favorable outcomes with air or short-acting gas tamponade[2](#tfn4-co-2-57){ref-type="table-fn"},[3](#tfn5-co-2-57){ref-type="table-fn"},[4](#tfn6-co-2-57){ref-type="table-fn"}
  Prone positioning   Importance of prone positioning                    Favorable outcomes in patients with inferior breaks without prone positioning[4](#tfn6-co-2-57){ref-type="table-fn"}

[@b37-co-2-57].

[@b21-co-2-57].

[@b20-co-2-57].

[@b22-co-2-57].

###### 

Selected case series of pars plana vitrectomy for rhegmatogenous retinal detachment

  Study            Number of patients   SOSR       Visual acuity outcomes   Comments
  ---------------- -------------------- ---------- ------------------------ --------------------------------------------------------
  [@b12-co-2-57]   29                   79%        ≥20/50 in 81%            Phakic and pseudophakic
  [@b9-co-2-57]    294                  86%--91%   Median 20/40             Pseudophakic
  [@b39-co-2-57]   78                   94%        ≥20/50 in 87%--88%       Pseudophakic
  [@b6-co-2-57]    22                   86%        Median 20/40             Phakic and pseudophakic
  [@b33-co-2-57]   205                  71%        ≥20/50 in 11%            Included PVR
  [@b37-co-2-57]   48                   81%        Mean 20/66               Inferior breaks
  [@b20-co-2-57]   15                   93%        Mean 20/30               Inferior breaks, pseudophakic, air as tamponade
  [@b20-co-2-57]   40                   90%        Mean 20/33               Inferior breaks, pseudophakic, no facedown positioning
  [@b14-co-2-57]   512                  71%        ≥20/50 in 48%            Included PVR, included some PPV/SB
  [@b16-co-2-57]   131                  87%        Mean 20/80               Phakic and pseudophakic
  [@b22-co-2-57]   60                   98%        Mean 20/59               Pseudophakic, aqueous tamponade

**Abbreviations:** PPV/SB, combined pars plana vitrectomy/scleral buckling; PVR, proliferative vitreoretinopathy.

Adapted from[@b40-co-2-57] and [@b34-co-2-57].

###### 

Selected retrospective comparative trials

  Number of patients                                                                                                       
  -------------------- ----- --------------------------------------------- ----------------------------------------------- ---------------------------------------------------
  [@b25-co-2-57]       55    47[\*](#tfn10-co-2-57){ref-type="table-fn"}   0                                               Equal (91% SB, 91% PPV)
  [@b24-co-2-57]       138   87[\*](#tfn10-co-2-57){ref-type="table-fn"}   0                                               Equal (92% SB, 92% PPV)
  [@b29-co-2-57]       60    10                                            30                                              Equivalent (98% SB, 93% PPV and SB/PPV combined)
  [@b1-co-2-57]        30    0                                             22[\*\*](#tfn11-co-2-57){ref-type="table-fn"}   Higher for SB/PPV (80% SB, 90% SB/PPV, p = 0.001)
  [@b48-co-2-57]       0     41                                            45                                              Equivalent (89% PPV, 73% SB/PPV, p = 0.11)
  [@b10-co-2-57]       92    19                                            0                                               Equivalent (85% SB, 95% PPV, no p value given)
  [@b31-co-2-57]       26    0                                             18                                              Equivalent (62% SB, 72% SB/PPV, p = 0.17)
  [@b47-co-2-57]       0     68                                            84                                              Equivalent (93% PPV, 94% SB/PPV, p = 0.75)

**Abbreviations:** PPV, Pars plana vitrectomy; RD, Retinal detachment; SB, Scleral buckling; SOSR, Single-operation success rate.

In these 2 studies, most patients in the PPV group underwent PPV only; however, a small (unreported) number of patients underwent combined SB/PPV in each study.

Used silicone oil as the tamponade agent. "Most" patients also underwent SB, but some were PPV only.

Adapted from[@b40-co-2-57] and [@b34-co-2-57].

###### 

Selected prospective comparative trials

  Number of patients                      
  ----------------------- ----- ---- ---- --------------------------------------------------------------------------------------------------------------------------------------------
  [@b43-co-2-57]\*        20    0    20   Equivalent SOSR (70% SB, 80% SB/PPV, p = 0.72), equivalent vision (median 20/120 SB, 20/200 SB/PPV, p = 0.4)
  Ahmadieh et al 2004\*   126   99   0    Equivalent SOSR (68% SB, 63% PPV, p = 0.24), equal vision (mean 20/182 SB, 20/182 PPV)
  [@b41-co-2-57]          0     45   26   Equivalent SOSR (98% PPV, 92% SB/PPV, no p value given), equivalent vision (improvement ≥3 lines in 60% PPV, 69% SB/PPV, no p value given)
  [@b38-co-2-57]\*        25    25   0    Equivalent SOSR (76% SB, 84% PPV, p = 0.48), better vision with PPV (20/105 SB, 20/71 PPV, p = 0.034)
  [@b7-co-2-57]\*         75    75   0    Higher SOSR for PPV (83% SB, 94% PPV, p = 0.037), equivalent vision (20/50 SB, 20/43 PPV, p = 0.26)

Randomized trial.

**Abbreviations:** RD, Retinal detachment; PPV, Pars plana vitrectomy; SB, Scleral buckling; SOSR, Single-operation success rate.

Adapted from [@b34-co-2-57].
